Advertisement

Topics

Latest Orthopedics NewsRSS

04:32 EST 23rd January 2019 | BioPortfolio

Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Psoriasis,Arthritis, Psoriatic,Crohn Disease, Date of authorisation: 15/01/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Psoriasis,Arthritis, Psoriatic,Crohn Disease, Date of authorisation: 15/01/2009, Revision: 27, Status: Authorised

Eligible Individuals with Hypophosphatasia to Receive Financial Assistance from The Assistance Fund

The Assistance Fund, an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, today announced the opening of a new financial assistance program for Hypophosphatasia. The program will assist eligible individuals with out-of-pocket medical expenses associated with treating the disorder....

$RARE Positive Topline Data from Ongoing Long-Term Extension Study of UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders https://globenewswire.com/news-release/2019/01/22/1703451/0/en/Ultragenyx-Announces-Positive-Topline-Data-from-Ongoi

$RARE Positive Topline Data from Ongoing Long-Term Extension Study of UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders https://globenewswire.com/news-release/2019/01/22/1703451/0/en/Ultragenyx-Announces-Positive-Topline-Data-from-Ongoing-Long-Term-Extension-Study-of-UX007-for-the-Treatment-of-Long-chain-Fatty-Acid-Oxidation-Disorders.html …

Bio-Thera Solutions Announces Initiation of Phase III Clinical Trial for BAT1806, a Proposed Biosimilar of Actemra® (Tocilizumab)

Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that dosing has begun in a Phase III clinical study for its tocilizumab biosimilar, BAT1806. Bio-Thera’s Phase III clinical trial will compare the safety and efficacy of BAT1806 and the reference product, Genentech’s RoActemra® in patients with rheumatoid arthritis (RA). Act...

HPMS to power AVCAD

908 Devices’ High-Pressure Mass Spectrometry (HPMS) Technology to Power Next-Generation Advanced Chemical Threat Detector for U.S. Department of Defense. The company and joint partner Smiths Detection selected to develop Aerosol and Vapor Chemical Agent Detector (AVCAD). 908 Devices Inc., a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, has announced they...

Coming Soon to the 2019 iaedp™ Symposium: Care for Body Image and Soul with Daily Healing Emphasis Yoga Sessions

Understanding the body and soul is at the core of the 2019 iaedp™ Symposium, hosting hundreds of professionals in the field of eating disorders. During this year’s conference, held February 7-10 at the JW Marriott Desert Springs Resort in Palm Desert, California, participants once again will attend the most comprehensive, creative and innovative educational program available in the eating diso...

Single infusion of rituximab slows development of rheumatoid arthritis – new research

One 1,000mg infusion of rituximab seems to slows the development of arthritis in people who are at risk of rheumatoid arthritis, experts highlight in the Annals of the Rheumatic Diseases. A total of 81 people with joint pain but no clinical evidence of arthritis were split into groups: 41 people received a 1,000mg infusion of […] The post Single infusion of rituximab slows development of rhe...

DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders

MINNEAPOLIS, Jan. 22, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (NASDAQ:DMAC) announces the publication of a paper titled  “Human Tissue Kallikrein In The Treatment Of Acute Ischemic Stroke” in the peer reviewed journal, Therapeutic Advances in Neurological Disorders (“TAND”). The paper summarizes the mechanistic rationale for using KLK1 to treat patients with acute ischemic...

Zebrafish to the Rescue

Who knew those animated little fish might do so much more for our patients with neurodevelopmental disorders than provide a calm diversion in the waiting room?

The Center for Biosimilars® Talks with Michael Kolodziej, M.D., About How Payers Are Preparing for Biosimilars

The interview was shared through the weekly e-newsletter of The Center for Biosimilars® The Center for Biosimilars®, an online resource for emerging therapies that focuses on improving patient outcomes,

Scientists have found a network of tiny blood vessels that travel through bones, a surprising discovery that might illuminate how drugs work. https://buff.ly/2RHxtmG 

Scientists have found a network of tiny blood vessels that travel through bones, a surprising discovery that might illuminate how drugs work. https://buff.ly/2RHxtmG 

Mesoblast Ltd MSB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryMesoblast Ltd Mesoblast is a regenerative medicine company, which develops regenerative cellbased products. Its pipeline product candidates include MPC150IM, which is under development for the treatment of chronic congestive heart failure; MSC100IV, for the treatment of acute graft versus host disease; MPC06ID, for the treatment of chronic low back pain CLBP; and MPC300IV for the treatment ...

Anatomy of surprise: Scientists discover hidden blood networks that cross through bone

Scientists have found a network of tiny blood vessels that travel through bones, a surprising discovery that might illuminate how drugs work.

Antibe Therapeutics Receives Approval to Initiate Part Two of Phase 2B Dose-Ranging, Efficacy Study for ATB-346

Antibe Therapeutics Inc. ("Antibe") (TSXV:ATE, OTCQB:ATBPF), a leader in developing safer therapeutics for pain and inflammation, is pleased to announce that it has received approval from Health Canada to initiate the second part of its Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346. The primary objective of the study is to evaluate ...

Global Rheumatic Disorders Drugs Market to 2024 Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry [Report Updated: 01012019] Prices from USD $4995

Global Rheumatic Disorders Drugs Market to 2024 Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent ExpirySummaryThe rheumatic disorder therapy area is multidisciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequen...

Global Women's Health Drugs Market to 2024 Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth [Report Updated: 01012019] Prices from USD $4995

Global Women's Health Drugs Market to 2024 Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive GrowthSummaryThe women's health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many o...

Salt appears to aggravate arthritis says new research

Sodium chloride – salt – is damaging for many aspects of health, and now a new study from Korea concludes that people with arthritis, particularly inflammatory forms, should avoid it where possible. Mice with arthritis were fed a normal or high-salt diet and subsequent features of arthritis were recorded. The more salt they ingested, the […] The post Salt appears to aggravate art...

Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis

Cytosolic phospholipase A2 group IVA (cPLA2α)-deficient mice are resistant to collagen-induced arthritis, suggesting that cPLA2α is an important therapeutic target. Here, the anti-inflammatory effects of the A...

An orthopedic surgeon’s bone broth journey

Many cooks traditionally use broth derived from simmered bones of fish, fowl, or four-footed critters to flavor soups and sauces. Recently, bone-broth bars have popped up around the country and serve a non-caffeinated, nutritious alternative to tea or coffee. In some of these health-conscious establishments, the owners claim that these drinks also have filling, cleansing, […] Find jobs at C...

Autifony Therapeutics achieves first milestone in agreement with Boehringer Ingelheim for a novel therapeutic approach to a range of CNS disorders

Stevenage, UK – 18 January 2019 – Autifony Therapeutics Limited (“Autifony”), a clinical stage company developing new drugs to treat serious disorders of the nervous system, today announced that the first milestone has successfully been achieved under Autifony’s option agreement with Boehringer Ingelheim. As announced previously, Boehringer Ingelheim acquired an exc...

Body sway reflects joint emotional expression in music ensemble performance

One- and two-stage surgical revision of infected shoulder prostheses following arthroplasty surgery: A systematic review and meta-analysis

Walk more to reduce fibromyalgia fatigue highlights large new study

People with fibromyalgia need encouragement to walk more as they will become less tired and have a lower chance of developing additional conditions, highlights a large study in Rehabilitation Nursing. A team analysed the profile of 920 women with fibromyalgia, looking at if they were given medical advice to walk to reduce their symptoms, which […] The post Walk more to reduce fibromyalgia fa...

STAT Plus: Public Citizen contends a letter from the National Osteoporosis Foundation creates a false impression that many patient groups object to Medicare price negotiations. https://buff.ly/2QWYwVC 

STAT Plus: Public Citizen contends a letter from the National Osteoporosis Foundation creates a false impression that many patient groups object to Medicare price negotiations. https://buff.ly/2QWYwVC 

Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: a case–control study

A high prevalence of periodontitis has been reported in rheumatoid arthritis (RA) patients, although the strength of this association, its temporal link and the possible relationship between the severity of pe...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Orthopedics market research data and corporate reports here